Fact checked by Nick Blackmer More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

While medications such as glucagon-like peptide 1 (GLP-1 ... trial to assess the efficacy and safety of AID in adults using multiple daily insulin injections or insulin pumps. A total of 319 patients ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded company.

The Control-IQ+ algorithm enables AID in conjunction with Tandem’s t:slim X2 and Mobi insulin pumps and a compatible ... only on oral agents, on GLP-1 [glucagon-like peptide 1] injections ...

working with Beta Bionics to supply the liquid glucagon that would be included in a dual-hormone pump that can provide diabetics with insulin for high blood sugar and glucagon for dangerous lows.

The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion ... are those that also administer glucagon. Beta Bionics' iLet has ...